Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18636437 | 0.89 | TMPRSS2 (0.43) | TMPRSS2 | |
| SCHEMBL21283652 | 0.89 | — | — | |
| SCHEMBL20078702 | 0.87 | TMPRSS2 (0.33) | TMPRSS2RIPK1 | |
| SCHEMBL22096276 | 0.86 | POLRMT (0.33) | TMPRSS2RIPK1 | |
| SCHEMBL20878404 | 0.84 | TMPRSS2 (0.32) | TMPRSS2 | |
| SCHEMBL20078672 | 0.82 | TMPRSS2 (0.36) | TMPRSS2RIPK1 | |
| SCHEMBL18636611 | 0.82 | TMPRSS2 (0.34) | TMPRSS2 | |
| SCHEMBL22739002 | 0.81 | KRAS (0.31) | RIPK1 | |
| SCHEMBL25512483 | 0.81 | RIPK1 (0.33) | RIPK1 | |
| SCHEMBL18636474 | 0.81 | TMPRSS2 (0.31) | TMPRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287029-A1 | ANTIVIRAL PRODRUGS, PHARMACEUTICAL FORMULATIONS, AND METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287029-A1 | ANTIVIRAL PRODRUGS, PHARMACEUTICAL FORMULATIONS, AND METHODS | MTAP, SARS1, RNGTT | TMPRSS2 181/4885RIPK1 1226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.